J Thorac Cardiovasc Surg 2008;135:240-242
© 2008 The American Association for Thoracic Surgery
Improving neurologic and quality-of-life outcomes in children with congenital heart disease: Past, present, and future
Gil Wernovsky, MD*
Cardiac Intensive Care Unit, The Cardiac Center at The Childrens Hospital of Philadelphia, and the University of Pennsylvania School of Medicine, Philadelphia, Pa.
Received for publication April 6, 2007; revisions received June 26, 2007; accepted for publication July 5, 2007.
* Address for reprints: Gil Wernovsky, MD, Pediatric Cardiology, 34th St and Civic Center Blvd, Philadelphia PA, 19104. (Email: Wernovsky{at}email.chop.edu).
They say that time changes things, but you actually have to change them yourself (Andy Warhol).
Prostaglandin and Echocardiography
Thats what started this whole journey. Before the end of the 1970s, most neonates with critical congenital heart disease (CHD) did not survive if their pulmonary or systemic blood flow was dependent on a patent ductus arteriosus. Even in the rare neonate who was lucky enough to have spontaneous patency of the ductus, making a complete diagnosis to plan cardiac surgery required catheterization; 30 years ago cardiac catheterization was associated with significant morbidity, especially in a fragile neonate. Its no wonder surgical mortality was so high in those days. Even though the technical aspects of cardiac surgery could be applied to small babies, the status of the infant entering the operating room was tenuous, and the infant not infrequently had an incomplete diagnosis.
Enter bedside noninvasive diagnostic capabilities and the availability of medical support to stabilize the infant. Mechanical ventilation was being applied to smaller and smaller infants, hemodynamic monitoring was improving, and the new subspecialty of cardiac intensive care allowed for increasingly stable babies to survive palliative and reparative procedures. Improvements in surgical technique and cardiopulmonary bypass followed soon thereafter. Intraoperative echocardiography increased the likelihood of leaving the operating room with a better understanding of the physiology of the neonate and status of the repair.
For those of us in the practice of pediatric cardiology, this was an exciting time indeed. Survival, even for infants with the most complex lesions, was now expected. Cardiologists and intensivists painted a very different prognosis for families than we had even 10 years earlier. However, with these successes came new realizations. As we began to observe these outpatients in larger numbers, we recognized that there was an unexpectedly high prevalence of psychosocial, neurologic, developmental, and psychiatric disabilities in the survivors as they entered and proceeded through formal education. Gross and fine motor delays, learning disabilities, inattention, hyperactivity, internalizing and externalizing behaviors, and speech and language difficulties have all been reported with disturbingly high frequency, approaching 40% to 50% in some subgroups.1
The neurodevelopmental burden of disease is, for many children and their families, much more significant than the daily impact of their CHD.E1
(See E-References on line.) Many families of teenagers with complex CHD and significant learning or behavioral problems openly ask me why they were not informed of these potential problems when their children were born. It is of little solace that I tell them that when their child was born in the late 1980s and early 1990s, there were simply not enough school-age survivors to know the true impact of CHD and its management on longer term quality of life. Fortunately, children and their parents began to participate in longitudinal clinical research efforts so that we might gain improved understanding of the types and frequency of neurodevelopmental dysfunction and begin to understand the mechanism(s) of injury.
Partnership and Equipoise
In this issue, the investigators at Childrens Hospital Boston present another in a series of important investigations aimed at improving our understanding of the mechanisms of central nervous system injury in the operating room and proposing changes in management to improve the longer term outlook for our current patients.2,3
At the outset, Newburger (cardiology), Jonas (cardiac surgery), Bellinger (psychology), Wypij (biostatistics), and their many colleagues understood the value in the multidisciplinary design of clinical investigations. I was fortunate as a junior physician to be mentored by that group. Partnership extended from study design through implementation in the intensive care unit, getting "buy-in" from colleagues in medicine, surgery, anesthesia, and nursing, and most importantly, the families of our patients. We believed then, as now, that clinical investigation of long-term outcomes was a moral imperative and all needed to participate as partners in the challenge, from many disciplines both inside and outside of pediatric cardiology and surgery. Whereas getting many investigators (frequently seasoned investigators with long research track records) to agree on the important questions, the patient population to study, the financial realities of clinical studies, and even the order of authors on manuscripts was "challenging," equipoise was perhaps the hardest of all hurdles to overcome. In our field, it is natural to "know" (or be expected to know) the "correct" approach to a procedure, the "right" diagnosis: the "truth." How can a surgeon with so much on the line be expected to "flip a coin" to decide what bypass strategy to use, what surgical technique to use? How could we convince parents of critically ill neonates to sign a consent form allowing us to be—by design—random in our decision making?E2
How could we convince our colleagues who referred patients to us to allow their patients to enter a clinical trial? These were difficult problems in theory, but the leadership in the cardiovascular program provided by Dr Aldo Castañeda and Dr James Lock continued to foster an approach that this was clearly the best way in which the field could move forward and improve results for the next generation. Multidisciplinary study groups were encouraged and indeed became the model of clinical investigation of long-term outcomes for our patients.
The knowledge gained from the randomized trials in Boston have included investigations of the use and duration of deep hypothermic circulatory arrest,4,5,E6-E11
pH management,6,E12
and, in the current issue, follow-up and further analysis on the effect of hematocrit management during cardiopulmonary bypass.2,3,E13
Much has been learned from these trials that has affected our current approaches to cardiopulmonary bypass and perioperative management. In addition to the lessons learned from the important trials in Boston, a subtle "culture change" has occurred in our field. New changes in technique are more frequently subjected to critical review and implemented as clinical trials rather than immediately adopted as "better" or "proven." Practice change by anecdote, seniority, or by comparing new techniques to historical controls is no longer a viable, acceptable strategy.E14
Additional randomized clinical trials of intraoperative and perioperative management have recently been publishedE15,E16
and are currently underway, including multicenter trials supported by the Pediatric Heart Network (www.pediatricheartnetwork.org/currentstudies.asp, accessed 2007).
Prospective and Evidence-based Studies
In addition to the randomized studies in Boston, a number of cohorts are currently being evaluated prospectively with protocol-driven follow-up to learn more about the impact of factors outside the operating room that affect long-term neurodevelopmental outcomes. Large cohorts of patients with heterogeneous CHD are currently being prospectively followed up at The Childrens Hospital of Philadelphia7,E17-E20
as well as at Montreal Childrens Hospital8,E21-E28
and the University Hospital in Aachen, Germany.9,E29-35
Additional prospective and cross-sectional reports are increasingly prevalent in the literature.E36-E42
All of the current evidence points to the fact that modifications of technique in the operating room, although important, contribute but a small fraction to the variability of longer term outcomes in the decades that follow neonatal cardiac intervention. Instead, nonmodifiable factors such as gestational age, birth weight, genetic syndromes and polymorphisms, maternal education, and socioeconomic status have been consistently and significantly implicated as major contributors to long-term outcome.E43
Therefore, prospective studies must continue to define the impact of modifiable risk factors: how we operate, when we operate, and importantly, how we manage the patient in the intensive care unit. During a typical hospitalization for neonatal heart surgery, only a small fraction of the total length of stay is spent in the operating room, where a disproportionate (though very important) amount of clinical investigation has taken place. Resources and clinical investigations need also to study management patterns in the intensive care unit. Changes in management must be accompanied by investigation into their short- and long-term impact to establish an evidence base to design future prospective follow-up studies and randomized treatment clinical trials. Just a few examples of practice patterns that have not been adequately studied for their impact on longer term neurodevelopment include timing of surgery in critical lesions, "routine" delayed sternal closure,E44-E47
management of hyperglycemia,E48,E49
temperature control,E50-E52
nutrition,E53
and the impact of mechanical ventilation/hyperventilationE54
on longer term outcomes. Some are likely to be important, and it is time to study factors in the intensive care unit as rigorously as we have studied factors in the operating room. We need to be more critical of our current strategies as being "right." We should model our trials and clinical investigations on the approach taken by the Boston group for nearly 20 years, to have equipoise regarding our current strategies, study them rigorously, in a multidisciplinary, multicenter, and importantly, long-term fashion. We may find that our practices and established techniques may be all wrong.
| See related articles on pages 347 and 355.
|
References
- Wernovsky G. Current insights regarding neurological and developmental abnormalities in children and young adults with complex congenital cardiac disease. Cardiol Young 2006;16(Suppl 1):92-104.[Medline]
- Newburger JW, Jonas RA, Soul J, Kussman BD, Bellinger DC, Laussen PC, et al. Randomized trial of hematocrit 25% versus 35% during hypothermic cardiopulmonary bypass in infant heart surgery. J Thorac Cardiovasc Surg 2008;135:347-354.[Abstract/Free Full Text]
- Wypij D, Jonas RA, Bellinger DC, del Nido PJ, Mayer Jr JE, Bacha EA, et al. The effect of hematocrit during hypothermic cardiopulmonary bypass in infant heart surgery: results from the combined Boston hematocrit trials. J Thorac Cardiovasc Surg 2008;135:355-360.[Abstract/Free Full Text]
- Wypij D, Newburger JW, Rappaport LA, duPlessis AJ, Jonas RA, Wernovsky G, et al. The effect of duration of deep hypothermic circulatory arrest in infant heart surgery on late neurodevelopment: the Boston Circulatory Arrest Trial. J Thorac Cardiovasc Surg 2003;126:1397-1403.[Abstract/Free Full Text]
- Bellinger DC, Wypij D, duPlessis AJ, Rappaport LA, Jonas RA, Wernovsky G, et al. Neurodevelopmental status at eight years in children with dextro-transposition of the great arteries: the Boston Circulatory Arrest Trial. J Thorac Cardiovasc Surg 2003;126:1385-1396.[Abstract/Free Full Text]
- du Plessis AJ, Jonas RA, Wypij D, Hickey PR, Riviello J, Wessel DL, et al. Perioperative effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg 1997;114:991-1000.[Abstract/Free Full Text]
- Gaynor JW, Gerdes M, Zackai EH, Bernbaum J, Wernovsky G, Clancy RR, et al. Apolipoprotein E genotype and neurodevelopmental sequelae of infant cardiac surgery. J Thorac Cardiovasc Surg 2003;126:1736-1745.[Abstract/Free Full Text]
- Majnemer A, Limperopoulos C, Shevell M, Rohlicek C, Rosenblatt B, Tchervenkov C. Health and well-being of children with congenital cardiac malformations, and their families, following open-heart surgery. Cardiol Young 2006;16:157-164.[Medline]
- Hovels-Gurich HH, Konrad K, Skorzenski D, Herpertz-Dahlmann B, Messmer BJ, Seghaye MC. Attentional dysfunction in children after corrective cardiac surgery in infancy. Ann Thorac Surg 2007;83:1425-1430.[Abstract/Free Full Text]
E-References
- Wray J, Maynard L. The needs of families of children with heart disease. J Dev Behav Pediatr 2006;27:11-17.[Medline]
- Hoehn KS, Wernovsky G, Rychik J, Gaynor JW, Spray TL, Feudtner C, et al. What factors are important to parents making decisions about neonatal research?. Arch Dis Child Fetal Neonatal Ed 2005;90:F267-F269.[Abstract/Free Full Text]
- McGrath E, Wypij D, Rappaport LA, Newburger JW, Bellinger DC. Prediction of IQ and achievement at age 8 years from neurodevelopmental status at age 1 year in children with D-transposition of the great arteries. Pediatrics 2004;114:e572-e576.[Abstract/Free Full Text]
- Bartlett JM, Wypij D, Bellinger DC, Rappaport LA, Heffner LJ, Jonas RA, et al. Effect of prenatal diagnosis on outcomes in D-transposition of the great arteries. Pediatrics 2004;113:e335-e340.[Abstract/Free Full Text]
- Newburger JW, Wypij D, Bellinger DC, du Plessis AJ, Kuban KC, Rappaport LA, et al. Length of stay after infant heart surgery is related to cognitive outcome at age 8 years. J Pediatr 2003;143:67-73.[Medline]
- Dunbar-Masterson C, Wypij D, Bellinger DC, Rappaport LA, Baker AL, Jonas RA, et al. General health status of children with D-transposition of the great arteries after the arterial switch operation. Circulation 2001;104(12 Suppl 1):I138-I142.[Medline]
- Bellinger DC, Wypij D, Kuban KC, Rappaport LA, Hickey PR, Wernovsky G, et al. Developmental and neurological status of children at 4 years of age after heart surgery with hypothermic circulatory arrest or low-flow cardiopulmonary bypass. Circulation 1999;100:526-532.[Abstract/Free Full Text]
- Rappaport LA, Wypij D, Bellinger DC, Helmers SL, Holmes GL, Barnes PD, et al. Relation of seizures after cardiac surgery in early infancy to neurodevelopmental outcome. Boston Circulatory Arrest Study Group. Circulation 1998;97:773-779.[Abstract/Free Full Text]
- Bellinger DC, Rappaport LA, Wypij D, Wernovsky G, Newburger JW. Patterns of developmental dysfunction after surgery during infancy to correct transposition of the great arteries. J Dev Behav Pediatr 1997;18:75-83.[Medline]
- Bellinger DC, Jonas RA, Rappaport LA, Wypij D, Wernovsky G, Kuban KC, et al. Developmental and neurologic status of children after heart surgery with hypothermic circulatory arrest or low-flow cardiopulmonary bypass. N Engl J Med 1995;332:549-555.[Medline]
- Bellinger DC, Wernovsky G, Rappaport LA, Mayer Jr JE, Castaneda AR, Farrell DM, et al. Cognitive development of children following early repair of transposition of the great arteries using deep hypothermic circulatory arrest. Pediatrics 1991;87:701-707.[Abstract/Free Full Text]
- Jonas RA, Bellinger DC, Rappaport LA, Wernovsky G, Hickey PR, Farrell DM, et al. Relation of pH strategy and developmental outcome after hypothermic circulatory arrest. J Thorac Cardiovasc Surg 1993;106:362-368.[Abstract]
- Jonas RA, Wypij D, Roth SJ, Bellinger DC, Visconti KJ, du Plessis AJ, et al. The influence of hemodilution on outcome after hypothermic cardiopulmonary bypass: results of a randomized trial in infants. J Thorac Cardiovasc Surg 2003;126:1765-1774.[Abstract/Free Full Text]
- Tabbutt S, Dominguez TE, Ravishankar C, Marino BS, Gruber PJ, Wernovsky G, et al. Outcomes after the stage I reconstruction comparing the right ventricular to pulmonary artery conduit with the modified Blalock Taussig shunt. Ann Thorac Surg 2005;80:1582-1590.[Abstract/Free Full Text]
- Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003;107:996-1002.[Abstract/Free Full Text]
- Mackie AS, Booth KL, Newburger JW, Gauvreau K, Huang SA, Laussen PC, et al. A randomized, double-blind, placebo-controlled pilot trial of triiodothyronine in neonatal heart surgery. J Thorac Cardiovasc Surg 2005;130:810-816.[Abstract/Free Full Text]
- Clancy RR, McGaurn SA, Goin JE, Hirtz DG, Norwood WI, Gaynor JW, et al. Allopurinol neurocardiac protection trial in infants undergoing heart surgery using deep hypothermic circulatory arrest. Pediatrics 2001;108:61-70.[Abstract/Free Full Text]
- Kaltman JR, Jarvik GP, Bernbaum J, Wernovsky G, Gerdes M, Zackai E, et al. Neurodevelopmental outcome after early repair of a ventricular septal defect with or without aortic arch obstruction. J Thorac Cardiovasc Surg 2006;131:792-798.[Abstract/Free Full Text]
- Kirshbom PM, Flynn TB, Clancy RR, Ittenbach RF, Hartman DM, Paridon SM, et al. Late neurodevelopmental outcome after repair of total anomalous pulmonary venous connection. J Thorac Cardiovasc Surg 2005;129:1091-1097.[Abstract/Free Full Text]
- Schultz AH, Jarvik GP, Wernovsky G, Bernbaum J, Clancy RR, DAgostino JA, et al. Effect of congenital heart disease on neurodevelopmental outcomes within multiple-gestation births. J Thorac Cardiovasc Surg 2005;130:1511-1516.[Abstract/Free Full Text]
- Majnemer A, Limperopoulos C, Shevell M, Rosenblatt B, Rohlicek C, Tchervenkov C. Long-term neuromotor outcome at school entry of infants with congenital heart defects requiring open-heart surgery. J Pediatr 2006;148:72-77.[Medline]
- Limperopoulos C, Majnemer A, Rosenblatt B, Shevell MI, Rohlicek C, Tchervenkov C. Agreement between the neonatal neurological examination and a standardized assessment of neurobehavioural performance in a group of high-risk newborns. Pediatr Rehabil 1997;1:9-14.[Medline]
- Limperopoulos C, Majnemer A, Shevell MI, Rosenblatt B, Rohlicek C, Tchervenkov C. Neurologic status of newborns with congenital heart defects before open heart surgery. Pediatrics 1999;103:402-408.[Abstract/Free Full Text]
- Limperopoulos C, Majnemer A, Shevell MI, Rosenblatt B, Rohlicek C, Tchervenkov C. Neurodevelopmental status of newborns and infants with congenital heart defects before and after open heart surgery. J Pediatr 2000;137:638-645.[Medline]
- Limperopoulos C, Majnemer A, Rosenblatt B, Shevell MI, Rohlicek C, Tchervenkov C, et al. Association between electroencephalographic findings and neurologic status in infants with congenital heart defects. J Child Neurol 2001;16:471-476.[Medline]
- Limperopoulos C, Majnemer A, Shevell MI, Rosenblatt B, Rohlicek C, Tchervenkov C, et al. Functional limitations in young children with congenital heart defects after cardiac surgery. Pediatrics 2001;108:1325-1331.[Abstract/Free Full Text]
- Limperopoulos C, Majnemer A, Shevell MI, Rohlicek C, Rosenblatt B, Tchervenkov C, et al. Predictors of developmental disabilities after open heart surgery in young children with congenital heart defects. J Pediatr 2002;141:51-58.[Medline]
- Majnemer A, Limperopoulos C. Developmental progress of children with congenital heart defects requiring open heart surgery. Semin Pediatr Neurol 1999;6:12-19.[Medline]
- Hovels-Gurich HH, Konrad K, Skorzenski D, Nacken C, Minkenberg R, Messmer BJ, et al. Long-term neurodevelopmental outcome and exercise capacity after corrective surgery for tetralogy of Fallot or ventricular septal defect in infancy. Ann Thorac Surg 2006;81:958-966.[Abstract/Free Full Text]
- Hovels-Gurich HH, Seghaye MC, Ma Q, Miskova M, Minkenberg R, Messmer BJ, et al. Long-term results of cardiac and general health status in children after neonatal arterial switch operation. Ann Thorac Surg 2003;75:935-943.[Abstract/Free Full Text]
- Hovels-Gurich HH, Konrad K, Wiesner M, Minkenberg R, Herpertz-Dahlmann B, Messmer BJ, et al. Long term behavioural outcome after neonatal arterial switch operation for transposition of the great arteries. Arch Dis Child 2002;87:506-510.[Abstract/Free Full Text]
- Hovels-Gurich HH, Seghaye MC, Schnitker R, Wiesner M, Huber W, Minkenberg R, et al. Long-term neurodevelopmental outcomes in school-aged children after neonatal arterial switch operation. J Thorac Cardiovasc Surg 2002;124:448-458.[Abstract/Free Full Text]
- Hovels-Gurich HH, Seghaye MC, Sigler M, Kotlarek F, Bartl A, Neuser J, et al. Neurodevelopmental outcome related to cerebral risk factors in children after neonatal arterial switch operation. Ann Thorac Surg 2001;71:881-888.[Abstract/Free Full Text]
- Hovels-Gurich HH, Seghaye MC, Dabritz S, Messmer BJ, von Bernuth G. Cardiological and general health status in preschool- and school-age children after neonatal arterial switch operation. Eur J Cardiothorac Surg 1997;12:593-601.[Abstract/Free Full Text]
- Hovels-Gurich HH, Seghaye MC, Dabritz S, Messmer BJ, von Bernuth G. Cognitive and motor development in preschool and school-aged children after neonatal arterial switch operation. J Thorac Cardiovasc Surg 1997;114:578-585.[Abstract/Free Full Text]
- Forbess JM, Visconti KJ, Bellinger DC, Jonas RA. Neurodevelopmental outcomes in children after the Fontan operation. Circulation 2001;104(12 Suppl 1):I127-I132.[Medline]
- Forbess JM, Visconti KJ, Hancock-Friesen C, Howe RC, Bellinger DC, Jonas RA. Neurodevelopmental outcome after congenital heart surgery: results from an institutional registry. Circulation 2002;106(12 Suppl 1):I95-I102.[Medline]
- Forbess JM, Visconti KJ, Bellinger DC, Howe RJ, Jonas RA. Neurodevelopmental outcomes after biventricular repair of congenital heart defects. J Thorac Cardiovasc Surg 2002;123:631-639.[Abstract/Free Full Text]
- Wernovsky G, Stiles KM, Gauvreau K, Gentles TL, duPlessis AJ, Bellinger DC, et al. Cognitive development after the Fontan operation. Circulation 2000;102:883-889.[Abstract/Free Full Text]
- Cheung PY, Chui N, Joffe AR, Rebeyka IM, Robertson CMT. Postoperative lactate concentrations predict the outcome of infants aged 6 weeks or less after intracardiac surgery: a cohort follow-up to 18 months. J Thorac Cardiovasc Surg 2005;130:837-843.[Abstract/Free Full Text]
- Dittrich H, Buhrer C, Grimmer I, Dittrich S, Abdul-Khaliq H, Lange PE. Neurodevelopment at 1 year of age in infants with congenital heart disease. Heart 2003;89:436-441.[Abstract/Free Full Text]
- Kern JH, Hinton VJ, Nereo NE, Hayes CJ, Gersony WM. Early developmental outcome after the Norwood procedure for hypoplastic left heart syndrome. Pediatrics 1998;102:1148-1152.[Abstract/Free Full Text]
- Gaynor JW, Wernovsky G, Jarvik GP, Bernbaum J, Gerdes M, Zackai E, et al. Patient characteristics are important determinants of neurodevelopmental outcome at one year of age after neonatal and infant cardiac surgery. J Thorac Cardiovasc Surg 2007;133:1344-1353.[Abstract/Free Full Text]
- Owens WA, Vitale N, Hasan A, Hamilton JRL. A policy of elective delayed sternal closure does not improve the outcome after arterial switch. Ann Thorac Surg 2001;71:1553-1555.[Abstract/Free Full Text]
- Riphagen S, McDougall M, Tibby SM, Alphonso N, Anderson D, Austin C, et al. "Early" delayed sternal closure following pediatric cardiac surgery. Ann Thorac Surg 2005;80:678-685.[Abstract/Free Full Text]
- Samir K, Riberi A, Ghez O, Ali M, Metras D, Kreitmann B. Delayed sternal closure: a life-saving measure in neonatal open heart surgery; could it be predictable?. Eur J Cardiothorac Surg 2002;21:787-793.[Abstract/Free Full Text]
- Tabbutt S, Duncan BW, McLaughlin D, Wessel DL, Jonas RA, Laussen PC. Delayed sternal closure after cardiac operations in a pediatric population. J Thorac Cardiovasc Surg 1997;113:886-893.[Abstract/Free Full Text]
- de Ferranti S, Gauvreau K, Hickey PR, Jonas RA, Wypij D, du Plessis A. Intraoperative hyperglycemia during infant cardiac surgery is not associated with adverse neurodevelopmental outcomes at 1, 4, and 8 years. Anesthesiology 2004;100:1345-1352.[Medline]
- Yates AR, Dyke PC, Taeed R, Hoffman TM, Hayes J, Feltes TF, et al. Hyperglycemia is a marker for poor outcome in the postoperative pediatric cardiac patient. Pediatr Crit Care Med 2006;7:351-355.[Medline]
- Cottrell SM, Morris KP, Davies P, Bellinger DC, Jonas RA, Newburger JW. Early postoperative body temperature and developmental outcome after open heart surgery in infants. Ann Thorac Surg 2004;77:66-71.[Abstract/Free Full Text]
- Sakamoto T, Zurakowski D, Duebener LF, Lidov HG, Holmes GL, Hurley RJ, et al. Interaction of temperature with hematocrit level and pH determines safe duration of hypothermic circulatory arrest. J Thorac Cardiovasc Surg 2004;128:220-232.[Abstract/Free Full Text]
- Tabbutt S, Ittenbach RF, Nicolson SC, Burnham N, Hittle S, Spray TL, et al. Intracardiac temperature monitoring in infants after cardiac surgery. J Thorac Cardiovasc Surg 2006;131:614-620.[Abstract/Free Full Text]
- Kelleher DK, Laussen P, Teixeira-Pinto A, Duggan C. Growth and correlates of nutritional status among infants with hypoplastic left heart syndrome (HLHS) after stage 1 Norwood procedure. Nutrition 2006;223:237-244.
- Bassan H, Gauvreau K, Newburger JW, Tsuji M, Limperopoulos C, Soul JS, et al. Identification of pressure passive cerebral perfusion and its mediators after infant cardiac surgery. Pediatr Res 2005;57:35-41.[Medline]
Related Articles
-
Randomized trial of hematocrit 25% versus 35% during hypothermic cardiopulmonary bypass in infant heart surgery
- Jane W. Newburger, Richard A. Jonas, Janet Soul, Barry D. Kussman, David C. Bellinger, Peter C. Laussen, Richard Robertson, John E. Mayer, Jr, Pedro J. del Nido, Emile A. Bacha, Joseph M. Forbess, Frank Pigula, Stephen J. Roth, Karen J. Visconti, Adre J. du Plessis, David M. Farrell, Ellen McGrath, Leonard A. Rappaport, and David Wypij
J. Thorac. Cardiovasc. Surg. 2008 135: 347-354.
[Abstract]
[Full Text]
[PDF]
-
The effect of hematocrit during hypothermic cardiopulmonary bypass in infant heart surgery: Results from the combined Boston hematocrit trials
- David Wypij, Richard A. Jonas, David C. Bellinger, Pedro J. Del Nido, John E. Mayer, Jr., Emile A. Bacha, Joseph M. Forbess, Frank Pigula, Peter C. Laussen, and Jane W. Newburger
J. Thorac. Cardiovasc. Surg. 2008 135: 355-360.
[Abstract]
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
J. M. Costello, A. Polito, D. W. Brown, T. F. McElrath, D. A. Graham, R. R. Thiagarajan, E. A. Bacha, C. K. Allan, J. N. Cohen, and P. C. Laussen
Birth Before 39 Weeks' Gestation Is Associated With Worse Outcomes in Neonates With Heart Disease
Pediatrics,
August 1, 2010;
126(2):
277 - 284.
[Abstract]
[Full Text]
[PDF]
|
 |
|